Spatio-temporal expression patterns of aurora kinases a, B, and C and cytoplasmic polyadenylation-element-binding protein in bovine oocytes during meiotic maturation

Biol Reprod. 2008 Feb;78(2):218-33. doi: 10.1095/biolreprod.107.061036. Epub 2007 Aug 8.

Abstract

Maturation of immature bovine oocytes requires cytoplasmic polyadenylation and synthesis of a number of proteins involved in meiotic progression and metaphase-II arrest. Aurora serine-threonine kinases--localized in centrosomes, chromosomes, and midbody--regulate chromosome segregation and cytokinesis in somatic cells. In frog and mouse oocytes, Aurora A regulates polyadenylation-dependent translation of several mRNAs such as MOS and CCNB1, presumably by phosphorylating CPEB, and Aurora B phosphorylates histone H3 during meiosis. We analyzed the expression of three Aurora kinase genes--AURKA, AURKB, and AURKC--in bovine oocytes during meiosis by reverse transcription followed by quantitative real-time PCR and immunodetection. Aurora A was the most abundant form in oocytes, both at mRNA and protein levels. AURKA protein progressively accumulated in the oocyte cytoplasm during antral follicle growth and in vitro maturation. AURKB associated with metaphase chromosomes. AURKB, AURKC, and Thr-phosphorylated AURKA were detected at a contractile ring/midbody during the first polar body extrusion. CPEB, localized in oocyte cytoplasm, was hyperphosphorylated during prophase/metaphase-I transition. Most CPEB degraded in metaphase-II oocytes and remnants remained localized in a contractile ring. Roscovitine, U0126, and metformin inhibited meiotic divisions; they all induced a decrease of CCNB1 and phospho-MAPK3/1 levels and prevented CPEB degradation. However, only metformin depleted AURKA. The Aurora kinase inhibitor VX680 at 100 nmol/L did not inhibit meiosis but led to multinuclear oocytes due to the failure of the polar body extrusion. Thus, in bovine oocyte meiosis, massive destruction of CPEB accompanies metaphase-I/II transition, and Aurora kinases participate in regulating segregation of the chromosomes, maintenance of metaphase-II, and formation of the first polar body.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aurora Kinase A
  • Aurora Kinase B
  • Aurora Kinase C
  • Aurora Kinases
  • Butadienes / pharmacology
  • CDC2 Protein Kinase / analysis
  • CDC2 Protein Kinase / genetics
  • CDC2 Protein Kinase / metabolism
  • Cattle
  • Cyclin B / analysis
  • Cyclin B / genetics
  • Cyclin B / metabolism
  • Cyclin B1
  • Cytoplasm / chemistry
  • Cytoplasm / metabolism
  • Embryo, Mammalian / metabolism
  • Female
  • Fertilization
  • Meiosis* / drug effects
  • Metformin / pharmacology
  • Nitriles / pharmacology
  • Oocytes / chemistry
  • Oocytes / growth & development*
  • Oocytes / metabolism
  • Piperazines / pharmacology
  • Polyadenylation
  • Protein Kinase Inhibitors / pharmacology
  • Protein Serine-Threonine Kinases / analysis
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • Proto-Oncogene Proteins c-mos / analysis
  • Proto-Oncogene Proteins c-mos / genetics
  • Proto-Oncogene Proteins c-mos / metabolism
  • Purines / pharmacology
  • RNA, Messenger / metabolism
  • Roscovitine
  • mRNA Cleavage and Polyadenylation Factors / analysis
  • mRNA Cleavage and Polyadenylation Factors / genetics
  • mRNA Cleavage and Polyadenylation Factors / metabolism*

Substances

  • Butadienes
  • Ccnb1 protein, mouse
  • Cyclin B
  • Cyclin B1
  • Nitriles
  • Piperazines
  • Protein Kinase Inhibitors
  • Purines
  • RNA, Messenger
  • U 0126
  • mRNA Cleavage and Polyadenylation Factors
  • Roscovitine
  • tozasertib
  • Metformin
  • Aurka protein, mouse
  • Aurkb protein, mouse
  • Aurkc protein, mouse
  • Aurora Kinase A
  • Aurora Kinase B
  • Aurora Kinase C
  • Aurora Kinases
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-mos
  • CDC2 Protein Kinase